The global High-Performance Liquid Chromatography Market was valued at USD 5.01 billion in 2024, expected to reach USD 7.74 billion by 2032 with a CAGR of 5.64%. The U.S. market was valued at USD 1.24 billion in 2024, projected to reach USD 1.83 billion by 2032 at a CAGR of 5.07%. Major players include Agilent Technologies, Thermo Fisher Scientific, and Shimadzu Corporation.

In 2024, instruments dominated the market share at 49.20%, with consumables & accessories expected to grow. Clinical research applications led with 42.31% market share, while pharmaceutical & biotechnology companies dominated end-use in 2024 at 58.5%. North America held the largest market share at 32.43% in 2024, with the Asia Pacific market growing at a 6.21% CAGR.

Recent developments include Agilent Technologies launching its second-generation LC Series portfolio and Waters Corporation introducing the Alliance iS Bio HPLC System. The report provides insights into application-specific trends, regional healthcare spending, automation rates, regulatory compliance, and technology upgrades. Market size in 2024 was USD 5.01 billion, expected to reach USD 7.74 billion by 2032 with a CAGR of 5.64%. Regional analysis covers North America, Europe, Asia Pacific, Middle East & Africa, and Latin America.

Read more at GlobeNewswire: High-Performance Liquid Chromatography Market to Reach USD